Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Kroenke

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Neuroscience Research|April 28, 2007
Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitisMark A Kroenke, Benjamin M Segal
Brain, Behavior, and Immunity|October 19, 2010
IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathwayMark A Kroenke, Benjamin M Segal
European Journal of Immunology|June 12, 2010
EAE mediated by a non-IFN-γ/non-IL-17 pathwayMark A Kroenke, Stephen W Chensue, Benjamin M Segal
The Journal of Experimental Medicine|April 28, 2010
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunizationIrah L King, Mark A Kroenke, Benjamin M Segal
The Journal of Experimental Medicine|June 25, 2008
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionMark A Kroenke, Thaddeus J Carlson, Anuska V Andjelkovic, et al.
The AAPS Journal|November 6, 2021
Immunogenicity Risk Assessment for Multi-specific TherapeuticsMark A Kroenke, Mark N Milton, Seema Kumar, et al.
Bioanalysis|December 6, 2012
Development and optimization of neutralizing antibody assays to monitor clinical immunogenicityFrancesca Civoli, Mark A Kroenke, Kaz Reynhardt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2012
Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiationMark A Kroenke, Danelle Eto, Michela Locci, et al.
The Journal of Experimental Medicine|April 1, 2015
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanismsKaterina Hatzi, J Philip Nance, Mark A Kroenke, et al.
Journal of Immunological Methods|March 10, 2017
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessmentsMark A Kroenke, Dohan K Weeraratne, Hongjie Deng, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Neuroscience Research|April 28, 2007
Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitisMark A Kroenke, Benjamin M Segal
Brain, Behavior, and Immunity|October 19, 2010
IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathwayMark A Kroenke, Benjamin M Segal
European Journal of Immunology|June 12, 2010
EAE mediated by a non-IFN-γ/non-IL-17 pathwayMark A Kroenke, Stephen W Chensue, Benjamin M Segal
The Journal of Experimental Medicine|April 28, 2010
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunizationIrah L King, Mark A Kroenke, Benjamin M Segal
The Journal of Experimental Medicine|June 25, 2008
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionMark A Kroenke, Thaddeus J Carlson, Anuska V Andjelkovic, et al.
The AAPS Journal|November 6, 2021
Immunogenicity Risk Assessment for Multi-specific TherapeuticsMark A Kroenke, Mark N Milton, Seema Kumar, et al.
Bioanalysis|December 6, 2012
Development and optimization of neutralizing antibody assays to monitor clinical immunogenicityFrancesca Civoli, Mark A Kroenke, Kaz Reynhardt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2012
Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiationMark A Kroenke, Danelle Eto, Michela Locci, et al.
The Journal of Experimental Medicine|April 1, 2015
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanismsKaterina Hatzi, J Philip Nance, Mark A Kroenke, et al.
Journal of Immunological Methods|March 10, 2017
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessmentsMark A Kroenke, Dohan K Weeraratne, Hongjie Deng, et al.
Pageof 2